PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2

Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCNEILLY, FRANCIS, HAINES, DEBORAH, HASSARD, LORI, CLARK, EDWARD, HARDING, JOHN, ALLAN, GORDON, MOORE, ELLIS, JOHN ALBERT, KRAKOWKA, GEORGE, STEVE, AUDONNET, JEANRISTOPHE, FRANCIS, CHARREYRE, CATHERINE, ELISABETH, CHAPPUIS, GILLES, EMILE, MEEHAN, BRIAN
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MCNEILLY, FRANCIS
HAINES, DEBORAH
HASSARD, LORI
CLARK, EDWARD
HARDING, JOHN
ALLAN, GORDON, MOORE
ELLIS, JOHN ALBERT
KRAKOWKA, GEORGE, STEVE
AUDONNET, JEANRISTOPHE, FRANCIS
CHARREYRE, CATHERINE, ELISABETH
CHAPPUIS, GILLES, EMILE
MEEHAN, BRIAN
description Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1246920B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1246920B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1246920B13</originalsourceid><addsrcrecordid>eNrjZLANCHINc_UL8fT3U_B3U3B0c3N1BnGCFRyDg_2dPR1DXF0Uwj1DPBQC_IOcPf1cFZw9g5z9wzyDQoN1jXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgKGRiZmlkYGToTERSgDzCSmT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><source>esp@cenet</source><creator>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</creator><creatorcontrib>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</creatorcontrib><description>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111005&amp;DB=EPODOC&amp;CC=EP&amp;NR=1246920B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111005&amp;DB=EPODOC&amp;CC=EP&amp;NR=1246920B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCNEILLY, FRANCIS</creatorcontrib><creatorcontrib>HAINES, DEBORAH</creatorcontrib><creatorcontrib>HASSARD, LORI</creatorcontrib><creatorcontrib>CLARK, EDWARD</creatorcontrib><creatorcontrib>HARDING, JOHN</creatorcontrib><creatorcontrib>ALLAN, GORDON, MOORE</creatorcontrib><creatorcontrib>ELLIS, JOHN ALBERT</creatorcontrib><creatorcontrib>KRAKOWKA, GEORGE, STEVE</creatorcontrib><creatorcontrib>AUDONNET, JEANRISTOPHE, FRANCIS</creatorcontrib><creatorcontrib>CHARREYRE, CATHERINE, ELISABETH</creatorcontrib><creatorcontrib>CHAPPUIS, GILLES, EMILE</creatorcontrib><creatorcontrib>MEEHAN, BRIAN</creatorcontrib><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><description>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLANCHINc_UL8fT3U_B3U3B0c3N1BnGCFRyDg_2dPR1DXF0Uwj1DPBQC_IOcPf1cFZw9g5z9wzyDQoN1jXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgKGRiZmlkYGToTERSgDzCSmT</recordid><startdate>20111005</startdate><enddate>20111005</enddate><creator>MCNEILLY, FRANCIS</creator><creator>HAINES, DEBORAH</creator><creator>HASSARD, LORI</creator><creator>CLARK, EDWARD</creator><creator>HARDING, JOHN</creator><creator>ALLAN, GORDON, MOORE</creator><creator>ELLIS, JOHN ALBERT</creator><creator>KRAKOWKA, GEORGE, STEVE</creator><creator>AUDONNET, JEANRISTOPHE, FRANCIS</creator><creator>CHARREYRE, CATHERINE, ELISABETH</creator><creator>CHAPPUIS, GILLES, EMILE</creator><creator>MEEHAN, BRIAN</creator><scope>EVB</scope></search><sort><creationdate>20111005</creationdate><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><author>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1246920B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MCNEILLY, FRANCIS</creatorcontrib><creatorcontrib>HAINES, DEBORAH</creatorcontrib><creatorcontrib>HASSARD, LORI</creatorcontrib><creatorcontrib>CLARK, EDWARD</creatorcontrib><creatorcontrib>HARDING, JOHN</creatorcontrib><creatorcontrib>ALLAN, GORDON, MOORE</creatorcontrib><creatorcontrib>ELLIS, JOHN ALBERT</creatorcontrib><creatorcontrib>KRAKOWKA, GEORGE, STEVE</creatorcontrib><creatorcontrib>AUDONNET, JEANRISTOPHE, FRANCIS</creatorcontrib><creatorcontrib>CHARREYRE, CATHERINE, ELISABETH</creatorcontrib><creatorcontrib>CHAPPUIS, GILLES, EMILE</creatorcontrib><creatorcontrib>MEEHAN, BRIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCNEILLY, FRANCIS</au><au>HAINES, DEBORAH</au><au>HASSARD, LORI</au><au>CLARK, EDWARD</au><au>HARDING, JOHN</au><au>ALLAN, GORDON, MOORE</au><au>ELLIS, JOHN ALBERT</au><au>KRAKOWKA, GEORGE, STEVE</au><au>AUDONNET, JEANRISTOPHE, FRANCIS</au><au>CHARREYRE, CATHERINE, ELISABETH</au><au>CHAPPUIS, GILLES, EMILE</au><au>MEEHAN, BRIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><date>2011-10-05</date><risdate>2011</risdate><abstract>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1246920B1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A09%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCNEILLY,%20FRANCIS&rft.date=2011-10-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1246920B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true